Fusen Pharmaceutical Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG370981030
HKD
0.78
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'17
Net Sales
165.72
Other Operating Income
0.00
Total Operating income
165.72
Raw Material Cost
75.94
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
0.00
Employee Cost
51.10
Power Cost
0.00
Manufacturing Expenses
7.11
Selling and Distribution Expenses
43.11
Other Expenses
-5.69
Total Expenditure (Excl Depreciation)
120.32
Operating Profit (PBDIT) excl Other Income
45.4
Other Income
1.20
Operating Profit (PBDIT)
51.87
Interest
7.11
Exceptional Items
-5.55
Gross Profit (PBDT)
89.78
Depreciation
5.03
Profit Before Tax
34.18
Tax
5.61
Provisions and contingencies
0.00
Profit After Tax
28.69
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
28.69
Share in Profit of Associates
0.00
Minority Interest
-0.12
Other related items
0.00
Consolidated Net Profit
28.57
Equity Capital
0.00
Face Value
0.0
Reserves
216.76
Earnings per share (EPS)
0.04
Diluted Earnings per share
0.04
Operating Profit Margin (Excl OI)
27.54%
Gross Profit Margin
23.66%
PAT Margin
17.31%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Quarterly Analysis Highlights - YoY
Markets Mojo
Analysis not available
Compare Quarterly Results Of Fusen Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
165.72
0
165.72
Other Operating Income
0.00
0.00
0.00
Total Operating income
165.72
0
165.72
Raw Material Cost
75.94
0
75.94
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
51.10
0
51.10
Power Cost
0
0
0.00
Manufacturing Expenses
7.11
0
7.11
Selling and Distribution Expenses
43.11
0
43.11
Other Expenses
-5.69
0.00
-5.69
Total Expenditure (Excl Depreciation)
120.32
0
120.32
Operating Profit (PBDIT) excl Other Income
45.40
0.00
45.40
Other Income
1.20
0
1.20
Operating Profit (PBDIT)
51.87
0
51.87
Interest
7.11
0
7.11
Exceptional Items
-5.55
0
-5.55
Gross Profit (PBDT)
89.78
0
89.78
Depreciation
5.03
0
5.03
Profit Before Tax
34.18
0
34.18
Tax
5.61
0
5.61
Provisions and contingencies
0.00
0
0.00
Profit After Tax
28.69
0
28.69
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.69
0
28.69
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.12
0
-0.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.57
0
28.57
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
216.76
0
216.76
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
27.54%
0%
0.00
27.54%
Gross Profit Margin
23.66%
0%
0.00
23.66%
PAT Margin
17.31%
0%
0.00
17.31%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %